Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|December 21, 2016
Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancerKyoichi Kaira, Yoshio Tomizawa, Hisao Imai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancerYoshio Tomizawa, Hironobu Iijima, Noriaki Sunaga, et al.
Thoracic Cancer|April 19, 2023
Clinical benefit of platinum doublet combination therapy in older adults with advanced non-small cell lung cancer: A prospective multicenter study by the National Hospital Organization in JapanMototsugu Shimokawa, Masaki Kanazu, Ryusei Saito, et al.
Carcinogenesis|January 12, 2010
Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypesTakashi Kohno, Hideo Kunitoh, Yoko Shimada, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2009
A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancerKyoichi Kaira, Noriaki Sunaga, Yoshio Tomizawa, et al.
Chemotherapy|February 1, 2014
Efficacy and safety of platinum combination chemotherapy re-challenge for relapsed patients with non-small-cell lung cancer after postoperative adjuvant chemotherapy of cisplatin plus vinorelbineHisao Imai, Takehito Shukuya, Reiko Yoshino, et al.
American Journal of Clinical Oncology|October 9, 2007
A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancerYoshio Tomizawa, Shin-ichi Ishihara, Hironobu Iijima, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2013
Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancerKyoichi Kaira, Yoshio Tomizawa, Reiko Yoshino, et al.
International Journal of Cancer|December 21, 2004
Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer riskTokuki Sakiyama, Takashi Kohno, Sachiyo Mimaki, et al.
Springerplus|April 22, 2015
Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapyHisao Imai, Kyoichi Kaira, Keita Mori, et al.
Pageof 7